(Q44499467)

3 December 2017

title

KIT in ovarian carcinoma: disillusion about a potential therapeutic target (English)

1 reference

3 December 2017

1 reference

8

Holger Moch

1 reference

3 December 2017

Gad Singer

1

1 reference

3 December 2017

Peter Schraml

2

1 reference

3 December 2017

Christopher Belgard

3

1 reference

3 December 2017

Anna Raggi

4

1 reference

3 December 2017

Stephan Dirnhofer

5

1 reference

3 December 2017

Philip Went

6

1 reference

3 December 2017

Michael J Mihatsch

7

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Journal of the National Cancer Institute

3 December 2017

published in

1 reference

3 December 2017

volume

95

1 reference

3 December 2017

issue

13

1 reference

3 December 2017

page(s)

1009-1010

1 reference

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.13.1009-A

Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.13.1009-A

Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.13.1009-A

Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.13.1009-A

Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.13.1009-A

10.1093/JNCI/95.13.1009-A

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference